Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 9 pp 8289—8300
Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells
Figure 3. Cellular uptake of Dox, PEG2000-DSPE (Dox) or P123-PEG2000-DSPE (Dox) by MCF-7R cells. Confocal images of MCF-7R cells treated with Dox, PEG2000-DSPE (Dox) or P123-PEG2000-DSPE (Dox) at 10 μg/mL for 0.5 and 1 h.